# Arum Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arum-therapeutics

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.arumtherapeutics.com
- Total disclosed funding: $7.2M
- Latest round: Series A (Apr 19, 2021)
- Investors on record: 5

## About

Based in Seoul, South Korea, and founded in 2019, Arum Therapeutics is a pharmaceutical company that focuses on the development of medicinal chemistry based on synthetic small molecules. The company's CEO and founder, Taegon Baik graduated from the University of Konkuk and served as head of the New Drug Discovery center at CJ CheilJedang.

The company is building up pipelines in cancer and rare disease. It focuses on the development of target-based antiviral agents for Asthma and COPD exacerbation, anticancer immunotherapy, and mono or combination anticancer agents.

## Funding rounds

- Series A, Apr 19, 2021, $7.2M — AJU IB Investment, KDB Capital, SBI Investment, Partners Investment, DAYLI Partners

## Investors

- AJU IB Investment (https://capitalatlas.ai/funds/aju-ib-investment) — Series A
- KDB Capital (https://capitalatlas.ai/funds/kdb-capital) — Series A
- SBI Investment (https://capitalatlas.ai/funds/sbi-investment) — Series A
- Partners Investment (https://capitalatlas.ai/funds/partners-investment) — Series A
- DAYLI Partners (https://capitalatlas.ai/funds/dayli-partners) — Series A